1 completed, 1 recruiting, 1 unknown. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Docetaxel: new trials by email Literature Review of Docetaxel trials Research Report on Docetaxel
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer Oxaliplatin plus S-1, Docetaxel plus S-1 - Gastric Cancer (GC), Adjuvant Chemotherapy | Phase 3 | Recruiting | Ruijin Hospital | 387 | 2025-12-15 | 2026-01-26 |
| A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours BH009 (Docetaxel injection), Docetaxel injection - Docetaxel, Solid Tumours | Phase 3 | Completed | Zhuhai Beihai Biotech Co., Ltd | 46 | 2021-04-29 | 2022-01-11 |
| FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma Irinotecan, 5-FU, Leucovorin - Stomach Neoplasms, Gastrointestinal Neoplasms | Phase 2 / Phase 3 | Unknown | Blokhin's Russian Cancer Research Center | 538 | 2019-01-29 | 2021-04-13 |
Stomach Neoplasms (2) · Gastrointestinal Neoplasms (1) · Neoplasms (1)
Digestive System Diseases (2) · Digestive System Neoplasms (2) · Gastrointestinal Diseases (2) · Neoplasms by Site (2) · Stomach Diseases (2) · Gastrointestinal Neoplasms (1) · Neoplasms (1)
Docetaxel (3) · Oxaliplatin (2) · Fluorouracil (1) · Injections (1) · Irinotecan (1) · Leucovorin (1) · S 1 (combination) (1)
Blokhin's Russian Cancer Research Center (1) · Ruijin Hospital (1) · Zhuhai Beihai Biotech Co., Ltd (1)
China (1) · India (1) · Russia (1)
Gopichand M, Ph. D. (1) · Ivan Stilidi, PhD (1)